MAM
XENT

Melqart Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Melqart Asset Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-835,819
Closed -$23.4M – 87
2022
Q1 		$23.4M Buy
835,819
+220,819
+36% +$6.05M 1.56% 25
2021
Q4 		$16.8M Buy
+615,000
New +$16.7M 0.85% 31

Melqart Asset Management's XENT Position: Q2 2022 in Review

Melqart Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 835,819 shares — an estimated $23.4M sold.

Melqart Asset Management first reported a position in XENT in Q4 2021 and held it in 2 quarters. The position peaked at $23.4M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Melqart Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Melqart Asset Management sold 835,819 Intersect ENT, Inc shares in Q2 2022, an estimated $23.4M.
  • Melqart Asset Management first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 2 quarters.
  • Melqart Asset Management's Intersect ENT, Inc position peaked at $23.4M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Melqart Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.